Tipranavir

Paul G. Auwaerter, M.D., Paul A. Pham, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID

INDICATIONS

FDA

  • Treatment of HIV+ pts with evidence of viral replication who are highly treatment-experienced or have HIV resistant to multiple PIs.

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.